Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68b0256b813270ffac595cb0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 100",
"description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.",
"price": 550.0,
"discountamount": 165.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2166,
"imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:46:19.602Z",
"updatedon": "2025-08-28T09:46:19.602Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 100 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68b02393f5434d48fca8b8ca",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 50",
"description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.",
"price": 375.0,
"discountamount": 112.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2165,
"imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:38:27.036Z",
"updatedon": "2025-08-28T09:38:27.036Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 50 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "681c5e9e5a26e4010ea42029",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ST-GLIPTIN M 100/ 1000",
"description": "ST-GLIPTIN M 100/1000 is an advanced oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus. This powerful combination of Sitagliptin (100 mg) and Metformin Hydrochloride (1000 mg) offers dual action in controlling elevated blood glucose levels, especially in patients who do not respond adequately to metformin or sitagliptin alone. It is intended for adults and is generally used in conjunction with diet and exercise to enhance glycemic control.\n\nKey Ingredients\nSitagliptin (100 mg)\nSitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.\n\nMetformin Hydrochloride (1000 mg)\nMetformin belongs to the biguanide class of antidiabetics. It works by reducing the amount of sugar produced by the liver and improves the body’s sensitivity to insulin, facilitating better glucose utilization.\n\nKey Benefits\nHelps reduce both fasting and postprandial (after-meal) blood glucose levels effectively\nImproves overall glycemic control in patients with Type 2 diabetes\nCombines two different mechanisms of action for better diabetes management\nMinimizes the risk of hypoglycemia compared to other antidiabetic therapies\nMay support weight neutrality or slight weight loss in diabetic individuals\n\nHow Does It Work?\nST-GLIPTIN M 100/1000 works through a synergistic mechanism by combining two effective antidiabetic agents:\n\nSitagliptin enhances the levels of incretin hormones, which help the pancreas produce more insulin and reduce the secretion of glucagon, especially when blood sugar is high.\nMetformin reduces hepatic glucose production and increases insulin sensitivity, which helps the body use glucose more efficiently.\nTogether, these agents provide comprehensive blood sugar control by addressing multiple physiological pathways involved in glucose metabolism.\n\nDirections for Use\nTake ST-GLIPTIN M 100/1000 exactly as prescribed by your physician.\nIt is typically taken once or twice daily with meals to reduce gastrointestinal side effects and optimize absorption.\nSwallow the tablet whole with water. Do not crush or chew the tablet.\nMaintain a balanced diet and follow an active lifestyle for best results.\nRegular blood sugar monitoring is essential to assess effectiveness and make any necessary dosage adjustments.\n\nSide Effects\nCommon side effects may include nausea, diarrhea, stomach upset, or headache.\nSome individuals may experience respiratory tract infections, sore throat, or a runny nose.\nLactic acidosis is a rare but serious side effect associated with high-dose metformin—seek immediate medical attention if symptoms like unusual fatigue, muscle pain, difficulty breathing, or abdominal discomfort occur.\nAllergic reactions such as rash, itching, or swelling are uncommon but possible.\nAlways inform your doctor of any persistent or bothersome side effects for timely intervention.",
"price": 225.0,
"discountamount": 68.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"1001000 works",
"100 1000stgliptin",
"work stgliptin",
"balanced diet",
"tablet maintain",
"diabetic individuals",
"sitagliptin 100 mg",
"timely intervention",
"rash itching",
"medical attention",
"highdose metforminseek",
"assess effectiveness",
"active lifestyle",
"pancreas produce",
"synergistic mechanism",
"antidiabetic therapies",
"hypoglycemia compared",
"glycemic control",
"biguanide class",
"incretin hormones",
"respond adequately",
"powerful combination",
"insulin facilitating",
"sugar produced",
"side effect",
"bodys sensitivity",
"effective management",
"blood sugar",
"increases insulin sensitivity",
"regulate blood sugar",
"glucose metabolism directions",
"increasing insulin release",
"bothersome side effects",
"diabetes management minimizes",
"optimize absorption swallow",
"slight weight loss",
"support weight neutrality"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2107,
"imageuri": "https://productimages.withfloats.com/actual/681c5e9f5e6dd8f19a0309c3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/681c5e9f5e6dd8f19a0309c3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-08T07:34:54.516Z",
"updatedon": "2025-05-08T07:35:36.782Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/st-gliptin-m-100-1000/2107",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "sitagliptin and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin and Metformin hydrochloride tablets Uses in Hindi",
"sitagliptin and metformin hydrochloride tablets 50/1000 uses in hindi",
"sitagliptin and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "674b0a7ee34075b8291b14f1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets",
"description": "Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.\n\n \nKey Benefits:\nEffective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.\nReduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.\nMinimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.\nImproves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.\nSustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.\nComprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.\nHow Does It Work?\nGlimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.\nVoglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.\nMetformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.\nTogether, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.\n\nDirections for Use:\nDosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.\nSwallow Whole: Do not crush or chew the tablet; it is designed for sustained release.\nTiming: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.\nFollow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.\nAlways consult your doctor before starting or adjusting your dosage.\n\nSide Effects:\nWhile Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nStomach discomfort or flatulence\nMild hypoglycemia (low blood sugar levels)\nRare but Serious Side Effects:\n\nSevere hypoglycemia\nLactic acidosis (from Metformin)\nAllergic reactions such as rash or itching\n\n",
"price": 153.0,
"discountamount": 46.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"prescribed dosage",
"ingredients address",
"glycemic control",
"targets fasting",
"generally welltolerated",
"glimiteris trio 0502500",
"optimal results",
"meals swallow",
"healthcare professional",
"holistic solution",
"multifaceted nature",
"cardiovascular issues",
"neuropathy retinopathy",
"insulin improving",
"bodys response",
"multiple pathways",
"synergistic combination",
"multifaceted approach",
"dosage side effects",
"delaying glucose absorption",
"postprandial blood glucose",
"metformin allergic reactions",
"diarrhea stomach discomfort",
"experience side effects",
"reduce gastrointestinal discomfort",
"work glimepiride stimulates",
"proven antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2016,
"imageuri": "https://productimages.withfloats.com/actual/674b0a80ec7bb8b7dcae8a8a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/674b0a80ec7bb8b7dcae8a8a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-11-30T12:52:14.799Z",
"updatedon": "2024-11-30T12:52:14.799Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-0-5-mg-voglibose-0-2-mg-metformin-hydrochloride-sr-500-mg-tablets/2016",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS TRIO 0.5/0.2/500 ",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662cd3e870e7b20c49e689e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VOGLIGOLD G3 M0.3 ",
"description": "VOGLIGOLD G3 M0.3 \nVoglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg\nIntroduction to VOGLIGOLD G3 M0.3\nVOGLIGOLD G3 M0.3 is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains three active ingredients: Voglibose 0.3mg, Glimepiride 3mg, and Metformin Hydrochloride 500mg. This multi-action formula targets different aspects of glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nVoglibose 0.3mg\nVoglibose is an alpha-glucosidase inhibitor that works by:\n\nSlowing Carbohydrate Absorption: Voglibose inhibits the alpha-glucosidase enzyme in the small intestine, delaying the breakdown of complex carbohydrates into glucose. This helps to smooth out postprandial (after-meal) blood glucose peaks.\nGlimepiride 3mg\nGlimepiride is a sulfonylurea that helps control blood sugar by:\n\nStimulating Insulin Secretion: Glimepiride stimulates the pancreas to release more insulin, which helps lower blood sugar levels, particularly after meals.\nMetformin Hydrochloride 500mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReducing Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproving Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreasing Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nBenefits of VOGLIGOLD G3 M0.3\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Voglibose, Glimepiride, and Metformin effectively manages both fasting and postprandial blood sugar levels.\nEnhanced Insulin Secretion and Sensitivity: Glimepiride enhances insulin secretion, while Metformin improves insulin sensitivity, and Voglibose slows carbohydrate absorption.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: The risk of hypoglycemia is minimized due to the complementary actions of the three components.\nWeight Neutrality: Metformin and Voglibose are generally weight neutral, making this combination favorable for patients concerned about weight gain associated with diabetes medications.\nHow to Use VOGLIGOLD G3 M0.3\nDosage and Administration\nRecommended Dosage: The typical dosage is one tablet taken once or twice daily, as prescribed by your healthcare provider.\nAdministration: Take the tablet with meals to reduce gastrointestinal side effects and enhance the absorption of Metformin. Swallow the tablet whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VOGLIGOLD G3 M0.3 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vogligold-g3-m0-3-134319",
"price": 185.0,
"discountamount": 55.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"meal",
"diet",
"Order",
"glass",
"water",
"EMAIL",
"liver",
"adults",
"amount",
"Fasting",
"readings",
"patients",
"pancreas",
"Low Risk",
"exercise",
"breakdown",
"same time",
"biguanide",
"Decreasing",
"one tablet",
"Guidelines",
"Glimepiride",
"Adjustments",
"weight gain",
"information",
"utilization",
"Optimal Use",
"best results",
"Introduction",
"sterispharma",
"sulfonylurea",
"Hypoglycemia",
"muscle cells",
"sterisonline",
"CALL/WHATSAPP",
"Voglibose 0.3",
"Administration",
"typical dosage",
"glucose uptake",
"treatment plan",
"Consistent Use",
"Key Components",
"small intestine",
"glycemic control",
"three components",
"VOGLIGOLD G3 M0.3",
"different aspects",
"Weight Neutrality",
"several mechanisms",
"glucose regulation",
"Regular monitoring",
"Recommended Dosage",
"blood glucose peaks",
"Insulin Sensitivity",
"healthcare provider",
"diabetes medications",
"effective management",
"multi-action formula",
"complex carbohydrates",
"Intestinal Absorption",
"complementary actions",
"gastrointestinal tract",
"combination medication",
"Metformin Hydrochloride",
"Carbohydrate Absorption",
"alpha-glucosidase enzyme",
"three active ingredients",
"type 2 diabetes mellitus",
"Enhanced Insulin Secretion",
"Additional Health Benefits",
"Hepatic Glucose Production",
"alpha-glucosidase inhibitor",
"gastrointestinal side effects",
"Postprandial Glucose Management",
"postprandial blood sugar levels",
"comprehensive blood sugar control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1519,
"imageuri": "https://productimages.withfloats.com/actual/667d30b6c303c6d6ad136ea4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d30b6c303c6d6ad136ea4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T09:05:02.904Z",
"updatedon": "2024-06-27T09:28:16.215Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vogligold-g3-m0-3-/1519",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VOGLIGOLD G3 M0.3 ",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride 3mg+metformin 500mg+voglibose 0.3 mg",
"voglibose glimepiride + metformin hydrochloride us",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662c81c7247ae19c482b3d9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE 100 ",
"description": "VILDIABATE 100 \nVildagliptin (100mg)\nIntroduction to VILDIABATE 100\nVILDIABATE 100 is an oral medication designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin helps regulate blood sugar levels by enhancing the body’s natural ability to produce insulin and control glucose production. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Component and Mechanism of Action\nVildagliptin 100mg\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These incretin hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin secretion in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 100\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 100\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 100 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452",
"price": 275.0,
"discountamount": 82.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"diet",
"body",
"EMAIL",
"Order",
"meals",
"water",
"glass",
"GLP-1",
"liver",
"adults",
"Action",
"amount",
"option",
"potent",
"readings",
"Low Risk",
"appetite",
"exercise",
"patients",
"same time",
"Mechanism",
"regulation",
"VILDIABATE",
"one tablet",
"Guidelines",
"management",
"food intake",
"weight gain",
"Optimal Use",
"information",
"conjunction",
"Adjustments",
"Introduction",
"Vildagliptin",
"sterisonline",
"best results",
"crucial role",
"DPP-4 enzyme",
"Hypoglycemia",
"instructions",
"sterispharma",
"Key Component",
"CALL/WHATSAPP",
"typical dosage",
"Consistent Use",
"Administration",
"treatment plan",
"Weight Neutral",
"natural ability",
"oral medication",
"low blood sugar",
"glucagon release",
"DPP-4) inhibitor",
"natural response",
"glycemic control",
"individual needs",
"gastric emptying",
"insulin secretion",
"incretin hormones",
"glucose metabolism",
"Recommended Dosage",
"Regular monitoring",
"healthcare provider",
"blood glucose levels",
"pancreatic beta cells",
"dipeptidyl peptidase-4",
"Fasting Glucose Control",
"meal) blood sugar levels",
"type 2 diabetes mellitus",
"glucose-dependent manner",
"selective DPP-4 inhibitor",
"Additional Health Benefits",
"hepatic glucose production",
"other diabetes medications",
"Postprandial Glucose Control",
"Effective Blood Sugar Control",
"glucose-dependent insulinotropic peptide"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1514,
"imageuri": "https://productimages.withfloats.com/actual/667d3bc9c134db5b38ba8354.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d3bc9c134db5b38ba8354.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T08:43:08.09Z",
"updatedon": "2024-06-27T10:15:31.785Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1514",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE 100 ",
"category": "DIABETIC RANGE",
"tags": [
"vildagliptin 100 mg uses",
"",
"vildagliptin 100 mg generic medicine",
"vildagliptin 100 mg side effects",
"",
"vildagliptin sustained release tablets 100 mg",
"vildagliptin 100 mg brands in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662c4c88ecffe165c354dc1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE PIO ",
"description": "VILDIABATE PIO \nVildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg\nIntroduction to VILDIABATE PIO\nVILDIABATE PIO is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains two active ingredients: Vildagliptin 50mg and Pioglitazone Hydrochloride 15mg. This dual-action formula targets different aspects of glucose regulation, providing comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nPioglitazone Hydrochloride 15mg\nPioglitazone is a thiazolidinedione that improves insulin sensitivity in muscle and adipose (fat) tissues. It works by:\n\nIncreasing Insulin Sensitivity: Pioglitazone enhances the body's response to insulin, allowing for better glucose uptake and utilization by cells.\nReducing Hepatic Glucose Production: Pioglitazone decreases the amount of glucose produced by the liver, helping to lower fasting blood sugar levels.\nBenefits of VILDIABATE PIO\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Vildagliptin and Pioglitazone effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Vildagliptin enhances insulin secretion in response to meals, while Pioglitazone improves insulin sensitivity in peripheral tissues.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nCardioprotective Effects: Pioglitazone may provide additional cardiovascular benefits, such as improving lipid profiles and reducing inflammation, which can be beneficial for patients with diabetes who are at risk of cardiovascular diseases.\nWeight Management: While Pioglitazone may cause some weight gain due to fluid retention, Vildagliptin is generally weight neutral, balancing the overall effect on body weight.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage of VILDIABATE PIO is one tablet taken once daily, preferably with a meal to enhance absorption and reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE PIO regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-pio-134257\n",
"price": 295.0,
"discountamount": 88.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"diet",
"Order",
"meals",
"EMAIL",
"cells",
"liver",
"water",
"glass",
"GLP-1",
"amount",
"muscle",
"adults",
"Fasting",
"adipose",
"patients",
"Low Risk",
"exercise",
"readings",
"response",
"Enhancing",
"same time",
"one tablet",
"Mechanisms",
"Increasing",
"Guidelines",
"absorption",
"utilization",
"Optimal Use",
"information",
"body weight",
"Adjustments",
"weight gain",
"DPP-4 enzyme",
"inflammation",
"Introduction",
"Vildagliptin",
"Hypoglycemia",
"sterispharma",
"best results",
"fat) tissues",
"sterisonline",
"CALL/WHATSAPP",
"Administration",
"VILDIABATE PIO",
"glucose uptake",
"Key Components",
"Consistent Use",
"treatment plan",
"overall effect",
"lipid profiles",
"typical dosage",
"Incretin Levels",
"low blood sugar",
"fluid retention",
"glycemic control",
"glucagon release",
"DPP-4) inhibitor",
"Weight Management",
"insulin secretion",
"incretin hormones",
"different aspects",
"thiazolidinedione",
"peripheral tissues",
"glucose regulation",
"Regular monitoring",
"healthcare provider",
"dual-action formula",
"insulin sensitivity",
"blood glucose levels",
"effective management",
"dipeptidyl peptidase-4",
"two active ingredients",
"combination medication",
"cardiovascular diseases",
"Cardioprotective Effects",
"type 2 diabetes mellitus",
"meal) blood sugar levels",
"glucose-dependent manner",
"Recommended Dosage Dosage",
"Pioglitazone Hydrochloride",
"Additional Health Benefits",
"Hepatic Glucose Production",
"gastrointestinal side effects",
"Postprandial Glucose Management",
"comprehensive blood sugar control",
"additional cardiovascular benefits",
"Improving Postprandial Glucose Control",
"glucose-dependent insulinotropic peptide"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1512,
"imageuri": "https://productimages.withfloats.com/actual/667d3d8c5443982e2f655655.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d3d8c5443982e2f655655.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T08:28:56.298Z",
"updatedon": "2024-06-27T10:23:02.274Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-pio-/1512",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE PIO ",
"category": "DIABETIC RANGE",
"tags": [
"vildagliptin metformin hydrochloride tablets uses",
"vildagliptin + metformin + glimepiride combination",
"vildagliptin 50 mg side effects",
"vildagliptin and pioglitazone hydrochloride"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662af26db100e1fdc2dcc17",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE M 1000 ",
"description": "VILDIABATE M 1000 \nMetformin (1000mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 1000\nVILDIABATE M 1000 is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains Metformin Hydrochloride Sustained Release (SR) 1000mg and Vildagliptin 50mg. This dual-action formula targets different pathways involved in glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 1000mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 1000\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin, in particular, has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 1000 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-1000-133453",
"price": 319.0,
"discountamount": 95.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"diet",
"GLP-1",
"Order",
"EMAIL",
"water",
"glass",
"liver",
"peaks",
"meals",
"adults",
"amount",
"option",
"troughs",
"Fasting",
"exercise",
"Low Risk",
"patients",
"response",
"readings",
"same time",
"Enhancing",
"biguanide",
"one tablet",
"Guidelines",
"Optimal Use",
"information",
"utilization",
"weight gain",
"Adjustments",
"Introduction",
"Vildagliptin",
"Metformin SR",
"VILDIABATE M",
"sterispharma",
"best results",
"Hypoglycemia",
"sterisonline",
"DPP-4 enzyme",
"muscle cells",
"CALL/WHATSAPP",
"Weight Neutral",
"Consistent Use",
"Administration",
"treatment plan",
"steady release",
"typical dosage",
"Key Components",
"glucose uptake",
"low blood sugar",
"Incretin Levels",
"gradual release",
"SR) formulation",
"glucagon release",
"glycemic control",
"Prolonged Effect",
"DPP-4) inhibitor",
"insulin secretion",
"incretin hormones",
"several mechanisms",
"different pathways",
"glucose regulation",
"Regular monitoring",
"dual-action formula",
"healthcare provider",
"Insulin Sensitivity",
"blood glucose levels",
"effective management",
"Intestinal Absorption",
"gastrointestinal tract",
"combination medication",
"dipeptidyl peptidase-4",
"type 2 diabetes mellitus",
"glucose-dependent manner",
"meal) blood sugar levels",
"Recommended Dosage Dosage",
"Additional Health Benefits",
"Hepatic Glucose Production",
"Extended Release Formulation",
"sustained-release formulation",
"prolonged therapeutic effects",
"immediate-release formulations",
"Postprandial Glucose Management",
"long-lasting blood sugar control",
"comprehensive blood sugar control",
"common gastrointestinal side effects",
"Reduced Gastrointestinal Side Effects",
"Improving Postprandial Glucose Control",
"glucose-dependent insulinotropic peptide",
"Metformin Hydrochloride Sustained Release"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1496,
"imageuri": "https://productimages.withfloats.com/actual/6662af29d878d473a9fda03d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6662af29d878d473a9fda03d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T06:56:38.67Z",
"updatedon": "2024-06-28T11:39:06.99Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-m-1000-/1496",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE M 1000 ",
"category": "DIABETIC RANGE",
"tags": [
"VILDIABATE M 1000",
"Metformin (1000mg)SR",
"Vildagliptin (50mg)",
"Vildagliptin 50mg side effects",
"Vildagliptin tablets 50 mg uses",
"Vildagliptin 50 mg price",
"Vildagliptin 50 mg and metformin 500 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662acf3161afa2274ff5e9d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE 50 ",
"description": "VILDIABATE 50 \nVildagliptin (50mg)\nIntroduction to VILDIABATE 50\nVILDIABATE 50 is an oral medication specifically designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin works by enhancing the body's natural ability to regulate blood sugar levels, especially after meals. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nMechanism of Action\nVildagliptin\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin release in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 50\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 50 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 50\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 50 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 50 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-50-133451",
"price": 249.0,
"discountamount": 74.7,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"body",
"diet",
"liver",
"Order",
"glass",
"meals",
"water",
"EMAIL",
"GLP-1",
"option",
"potent",
"adults",
"amount",
"readings",
"Low Risk",
"appetite",
"patients",
"exercise",
"Mechanism",
"same time",
"one tablet",
"regulation",
"VILDIABATE",
"Guidelines",
"management",
"Adjustments",
"weight gain",
"information",
"Optimal Use",
"food intake",
"conjunction",
"Introduction",
"sterisonline",
"crucial role",
"DPP-4 enzyme",
"Hypoglycemia",
"instructions",
"sterispharma",
"best results",
"CALL/WHATSAPP",
"treatment plan",
"Consistent Use",
"Weight Neutral",
"typical dosage",
"Administration",
"natural ability",
"oral medication",
"low blood sugar",
"insulin release",
"glucagon release",
"natural response",
"DPP-4) inhibitor",
"gastric emptying",
"individual needs",
"glycemic control",
"incretin hormones",
"insulin secretion",
"Regular monitoring",
"glucose metabolism",
"Recommended Dosage",
"Action Vildagliptin",
"healthcare provider",
"blood glucose levels",
"pancreatic beta cells",
"dipeptidyl peptidase-4",
"Fasting Glucose Control",
"meal) blood sugar levels",
"type 2 diabetes mellitus",
"glucose-dependent manner",
"selective DPP-4 inhibitor",
"other diabetes medications",
"hepatic glucose production",
"Additional Health Benefits",
"Postprandial Glucose Control",
"Effective Blood Sugar Control",
"glucose-dependent insulinotropic peptide"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1494,
"imageuri": "https://productimages.withfloats.com/actual/6662acf5364f23242470bc7d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6662acf5364f23242470bc7d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T06:47:15.345Z",
"updatedon": "2024-06-28T11:41:29.762Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-50-/1494",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE 50 ",
"category": "DIABETIC RANGE",
"tags": [
"VILDIABATE 50",
"Vildagliptin (50mg)",
"Vildagliptin 50mg side effects",
"Vildagliptin tablets 50 mg uses",
"Vildagliptin 50 mg price",
"Vildagliptin 50 mg and metformin 500 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}